- Home
- MNY vs IBIO Comparison
MNY vs IBIO Comparison
Compare MNY & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNY
- IBIO
- Stock Information
- Founded
- MNY 2014
- IBIO 2008
- Country
- MNY Singapore
- IBIO United States
- Employees
- MNY N/A
- IBIO N/A
- Industry
- MNY
- IBIO Biotechnology: Pharmaceutical Preparations
- Sector
- MNY
- IBIO Health Care
- Exchange
- MNY Nasdaq
- IBIO Nasdaq
- Market Cap
- MNY 30.4M
- IBIO 24.3M
- IPO Year
- MNY N/A
- IBIO N/A
- Fundamental
- Price
- MNY $0.74
- IBIO $0.89
- Analyst Decision
- MNY
- IBIO Strong Buy
- Analyst Count
- MNY 0
- IBIO 3
- Target Price
- MNY N/A
- IBIO $4.87
- AVG Volume (30 Days)
- MNY 67.2K
- IBIO 720.0K
- Earning Date
- MNY 04-29-2025
- IBIO 05-12-2025
- Dividend Yield
- MNY N/A
- IBIO N/A
- EPS Growth
- MNY N/A
- IBIO N/A
- EPS
- MNY N/A
- IBIO N/A
- Revenue
- MNY $90,185,081.00
- IBIO $375,000.00
- Revenue This Year
- MNY $18.50
- IBIO $36.00
- Revenue Next Year
- MNY $24.83
- IBIO $33.33
- P/E Ratio
- MNY N/A
- IBIO N/A
- Revenue Growth
- MNY 24.60
- IBIO 650.00
- 52 Week Low
- MNY $0.55
- IBIO $1.03
- 52 Week High
- MNY $2.75
- IBIO $6.89
- Technical
- Relative Strength Index (RSI)
- MNY 47.32
- IBIO 18.58
- Support Level
- MNY $0.55
- IBIO $1.08
- Resistance Level
- MNY $0.80
- IBIO $1.33
- Average True Range (ATR)
- MNY 0.10
- IBIO 0.37
- MACD
- MNY 0.01
- IBIO -0.21
- Stochastic Oscillator
- MNY 70.26
- IBIO 0.60
About MNY MoneyHero Limited
MoneyHero Ltd is a personal finance aggregation and comparison company in Greater Southeast Asia. The firm is involved in the operation of online financial comparison platforms and related services for credit cards, personal loans, mortgages, insurance, and other financial products, connecting the providers of these products with well-matched and ready-to-transact consumers and generating revenue directly from these providers for placing their products on its platforms and providing insurance brokerage, marketing and events-related services.
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.